LATIN AMERICA HORMONE REPLACEMENT THERAPY MARKET 2021-2028
TABLE OF CONTENTS
1. LATIN AMERICA HORMONE REPLACEMENT
THERAPY MARKET - SUMMARY
2. INDUSTRY OUTLOOK
2.1. IMPACT OF COVID-19 ON HORMONE
REPLACEMENT THERAPY MARKET
2.2. KEY INSIGHTS
1.1.1. INTRODUCTION OF NEW DRUG DELIVERY
SYSTEMS FOR HORMONE REPLACEMENT
1.1.2. MODERN SEDENTARY LIFESTYLES
1.2. PORTER’S FIVE FORCES MODEL
1.1.1. THREAT OF NEW ENTRANTS
1.1.2. THREAT OF SUBSTITUTE PRODUCTS
1.1.3. BARGAINING POWER OF BUYERS
1.1.4. BARGAINING POWER OF SUPPLIERS
1.1.5. COMPETITIVE RIVALRY
1.2. MARKET ATTRACTIVENESS INDEX
1.3. VENDOR SCORECARD
1.4. KEY STRATEGIC DEVELOPMENTS
1.1.1. ACQUISITIONS & MERGERS
1.1.2. PRODUCT LAUNCH & DEVELOPMENTS
1.1.3. CONTRACTS AND PARTNERSHIPS
1.1.4. BUSINESS EXPANSIONS, ANNOUNCEMENTS,
& DIVESTITURES
1.2. MARKET DRIVERS
1.1.1. RISE IN AWARENESS PERTAINING TO
HEALTH PROBLEMS DURING MENOPAUSE
1.1.2. INCREASE IN PREVALENCE OF HORMONAL
DISORDERS
1.1.3. NEW PRODUCT LAUNCHES BY MAJOR GIANTS
1.2. MARKET RESTRAINTS
1.1.1. HIGH COST OF TREATMENT
1.1.2. ADVERSE REACTIONS ASSOCIATED WITH
HORMONE REPLACEMENT THERAPY
1.2. MARKET OPPORTUNITIES
1.1.1. AVAILABILITY OF ALTERNATIVE THERAPY
OFFERS OPPORTUNITIES FOR THE MARKET’S GROWTH
1.1.2. LAUNCH OF TELEMEDICINE CLINICAL
PRACTICE SERVICES
2. LATIN AMERICA HORMONE REPLACEMENT
THERAPY MARKET - BY THERAPY TYPE
2.1. ESTROGEN HORMONE REPLACEMENT THERAPY
2.2. THYROID HORMONE REPLACEMENT THERAPY
2.3. TESTOSTERONE HORMONE REPLACEMENT
THERAPY
2.4. HUMAN GROWTH HORMONE REPLACEMENT
THERAPY
2.5. PROGESTOGEN HORMONE REPLACEMENT THERAPY
3. LATIN AMERICA HORMONE REPLACEMENT
THERAPY MARKET - BY TYPE OF DISEASE
3.1. MENOPAUSE
3.2. MALE HYPOGONADISM
3.3. GROWTH HORMONE DEFICIENCY
3.4. HYPOTHYROIDISM
3.5. OTHER TYPE OF DISEASES
4. LATIN AMERICA HORMONE REPLACEMENT
THERAPY MARKET - BY ROUTE OF ADMINISTRATION
4.1. ORAL
4.2. PARENTERAL
4.3. TRANSDERMAL
4.4. OTHER ROUTES OF ADMINISTRATION
5. LATIN AMERICA HORMONE REPLACEMENT
THERAPY INDUSTRY – COUNTRY OUTLOOK
5.1. MEXICO
5.2. BRAZIL
5.3. REST OF LATIN AMERICA
6. COMPETITIVE LANDSCAPE
1.1. ABBOTT LABORATORIES
1.2. AMGEN
1.3. ANI PHARMACEUTICALS
1.4. BAYER AG
1.5. DR REDDY’S LABORATORIES LTD
1.6. ELI LILLY & COMPANY
1.7. GENENTECH INC
1.8. IPSEN
1.9. MERCK KGAA
1.10.
NOVARTIS AG
1.11.
NOVEN PHARMACEUTICALS INC
1.12.
NOVO NORDISK A/S
1.13.
PFIZER INC
1.14.
TEVA PHARMACEUTICAL INDUSTRIES LTD
1.15.
VIATRIS INC (MYLAN NV)
2. RESEARCH METHODOLOGY & SCOPE
2.1. RESEARCH SCOPE & DELIVERABLES
1.1.1. OBJECTIVES OF STUDY
1.1.2. SCOPE OF STUDY
1.2. SOURCES OF DATA
1.2.1. PRIMARY DATA SOURCES
1.2.2. SECONDARY DATA SOURCES
1.3. RESEARCH METHODOLOGY
1.3.1. EVALUATION OF PROPOSED MARKET
1.3.2. IDENTIFICATION OF DATA SOURCES
1.3.3. ASSESSMENT OF MARKET DETERMINANTS
1.3.4. DATA COLLECTION
1.3.5.
DATA VALIDATION & ANALYSIS
LIST OF TABLES
TABLE 1: LATIN AMERICA HORMONE
REPLACEMENT THERAPY MARKET, COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)
TABLE 2: VENDOR SCORECARD
TABLE 3: LIST OF ACQUISITIONS
& MERGERS
TABLE 4: LIST OF PRODUCT
LAUNCHES & DEVELOPMENTS
TABLE 5: LIST OF CONTRACTS AND
PARTNERSHIPS
TABLE 6: LATIN AMERICA HORMONE
REPLACEMENT THERAPY MARKET, COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)
TABLE 7: LATIN AMERICA HORMONE
REPLACEMENT THERAPY MARKET, BY THERAPY TYPE, 2021-2028 (IN $ MILLION)
TABLE 8: LATIN AMERICA HORMONE
REPLACEMENT THERAPY MARKET, BY TYPE OF DISEASE, 2021-2028 (IN $ MILLION)
TABLE 9: LATIN AMERICA HORMONE
REPLACEMENT THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2028 (IN $
MILLION)
LIST OF FIGURES
FIGURE 1: LATIN AMERICA HORMONE
REPLACEMENT THERAPY MARKET 2021-2028 (IN $ MILLION)
FIGURE 2: LATIN AMERICA HORMONE
REPLACEMENT THERAPY MARKET, BY THERAPY TYPE, 2020 & 2028 (IN %)
FIGURE 3: LATIN AMERICA HORMONE
REPLACEMENT THERAPY MARKET, BY ESTROGEN HORMONE REPLACEMENT THERAPY, 2021-2028
(IN $ MILLION)
FIGURE 4: LATIN AMERICA HORMONE
REPLACEMENT THERAPY MARKET, BY THYROID HORMONE REPLACEMENT THERAPY, 2021-2028
(IN $ MILLION)
FIGURE 5: LATIN AMERICA HORMONE
REPLACEMENT THERAPY MARKET, BY TESTOSTERONE HORMONE REPLACEMENT THERAPY,
2021-2028 (IN $ MILLION)
FIGURE 6: LATIN AMERICA HORMONE
REPLACEMENT THERAPY MARKET, BY HUMAN GROWTH HORMONE REPLACEMENT THERAPY,
2021-2028 (IN $ MILLION)
FIGURE 7: LATIN AMERICA HORMONE
REPLACEMENT THERAPY MARKET, BY PROGESTOGEN HORMONE REPLACEMENT THERAPY,
2021-2028 (IN $ MILLION)
FIGURE 8: LATIN AMERICA HORMONE
REPLACEMENT THERAPY MARKET, BY TYPE OF DISEASE, 2020 & 2028 (IN %)
FIGURE 9: LATIN AMERICA HORMONE
REPLACEMENT THERAPY MARKET, BY MENOPAUSE, 2021-2028 (IN $ MILLION)
FIGURE 10: LATIN AMERICA HORMONE
REPLACEMENT THERAPY MARKET, BY MALE HYPOGONADISM, 2021-2028 (IN $ MILLION)
FIGURE 11: LATIN AMERICA HORMONE
REPLACEMENT THERAPY MARKET, BY GROWTH HORMONE DEFICIENCY, 2021-2028 (IN $
MILLION)
FIGURE 12: LATIN AMERICA HORMONE
REPLACEMENT THERAPY MARKET, BY HYPOTHYROIDISM, 2021-2028 (IN $ MILLION)
FIGURE 13: LATIN AMERICA HORMONE
REPLACEMENT THERAPY MARKET, BY OTHER TYPE OF DISEASES, 2021-2028 (IN $ MILLION)
FIGURE 14: LATIN AMERICA HORMONE
REPLACEMENT THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2020 & 2028 (IN %)
FIGURE 15: LATIN AMERICA HORMONE
REPLACEMENT THERAPY MARKET, BY ORAL, 2021-2028 (IN $ MILLION)
FIGURE 16: LATIN AMERICA HORMONE
REPLACEMENT THERAPY MARKET, BY PARENTERAL, 2021-2028 (IN $ MILLION)
FIGURE 17: LATIN AMERICA HORMONE
REPLACEMENT THERAPY MARKET, BY TRANSDERMAL, 2021-2028 (IN $ MILLION)
FIGURE 18: LATIN AMERICA HORMONE
REPLACEMENT THERAPY MARKET, BY OTHER ROUTES OF ADMINISTRATION, 2021-2028 (IN $
MILLION)
FIGURE 19: MEXICO HORMONE
REPLACEMENT THERAPY MARKET 2021-2028 (IN $ MILLION)
FIGURE 20: BRAZIL HORMONE REPLACEMENT
THERAPY MARKET 2021-2028 (IN $ MILLION)
FIGURE 21: REST OF LATIN AMERICA
HORMONE REPLACEMENT THERAPY MARKET 2021-2028 (IN $ MILLION)
MARKET OUTLOOK
Triton’s research report insinuates that the Latin American hormone
replacement therapy market is likely to display a growth trend at a CAGR of
6.97% during the evaluated phase 2021-2028. Mexico, Brazil, and Rest of Latin
America outline the market in this region.
The studied market’s growth can be attributed to Sistema Unico de Saude,
the public health system covering health insurance for citizens across Brazil.
Additionally, there is a high prevalence of infectious diseases, owing to the
moderate standard of living. This surges the need for efficient and advanced
diagnostic and treatment options. Furthermore, the country’s focus on
testosterone replacement therapy is another factor supporting the growth of the
hormone replacement therapy market. Besides, the growing need for testosterone
hormone therapy for transgender people is augmenting the expansion of the
Brazilian hormone replacement therapy market.
In Rest of Latin America, the market is saturated and is evaluated to
grow at a moderate pace over the forecast period. This is mainly due to generic
erosion, coupled with the implementation of strict regulations by the FDA.
Additionally, in most cases, costs are not reimbursed by the insurers,
increasing the financial burden on the patients. However, an increase in
advancements in drug delivery methods and reformulation of approved drugs
amplifies the demand for hormone therapy, in turn, driving the hormone
replacement therapy market’s progression across the region’s nations.
COMPETITIVE OUTLOOK
Some of the renowned companies in the hormone
replacement therapy market include Noven Pharmaceuticals Inc, Pfizer Inc,
Viatris Inc (Mylan NV), Ipsen, Novo Nordisk A/S, Eli Lilly & Company, and
Merck KGAA.
Get more insights into the Latin America Hormone
Replacement Therapy Market:
https://www.tritonmarketresearch.com/reports/latin-america-hormone-replacement-therapy-market
1. ABBOTT LABORATORIES
2. AMGEN
3. ANI PHARMACEUTICALS
4. BAYER AG
5. DR REDDY’S LABORATORIES LTD
6. ELI LILLY & COMPANY
7. GENENTECH INC
8. IPSEN
9. MERCK KGAA
10. NOVARTIS AG
11. NOVEN PHARMACEUTICALS INC
12. NOVO NORDISK A/S
13. PFIZER INC
14. TEVA PHARMACEUTICAL INDUSTRIES LTD
15.
VIATRIS INC (MYLAN NV)
Comments
Post a Comment